Premium
Gain of function by phosphorylation in Presenilin 1‐mediated regulation of insulin signaling
Author(s) -
Maesako Masato,
Uemura Kengo,
Kuzuya Akira,
Sasaki Kazuki,
Asada Megumi,
Watanabe Kiwamu,
Ando Koichi,
Kubota Masakazu,
Akiyama Haruhiko,
Takahashi Ryosuke,
Kihara Takeshi,
Shimohama Shun,
Kinoshita Ayae
Publication year - 2012
Publication title -
journal of neurochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.75
H-Index - 229
eISSN - 1471-4159
pISSN - 0022-3042
DOI - 10.1111/j.1471-4159.2012.07741.x
Subject(s) - phosphorylation , presenilin , insulin receptor , signal transduction , gsk 3 , insulin , transcription factor , endocrinology , medicine , biology , microbiology and biotechnology , kinase , serine , glycogen synthase , insulin resistance , chemistry , gene , biochemistry , alzheimer's disease , disease
J. Neurochem. (2012) 121 , 964–973. Abstract We have recently reported that Presenilin 1 (PS1), a causative gene of familial Alzheimer disease (AD), down‐regulates the expression level of insulin receptor (IR) as well as its signaling through a γ‐secretase‐independent pathway. PS1 is phosphorylated by glycogen synthase kinase 3 β at the serine 353 and 357 residues. The main purpose of the present study was to clarify the effect of PS1 phosphorylation on IR/insulin signaling. Here, we demonstrate that the pseudo‐phosphorylation mutant of PS1 inhibited IR transcription and reduced IR expression compared with wild‐type PS1. Importantly, there was a decrease in expression of IR in AD brains, and the phosphorylation ratio of PS1 was negatively correlated with IR level in human brain samples. In the data from mouse models of AD, IR reduction was not observed at the pre‐Aβ deposition stage but became apparent in that of post‐Aβ deposition. Together with our previous reports, these results suggest that phosphorylated PS1 can promote the down‐regulation of insulin signaling, which may be a positive feed‐forward mechanism inhibiting insulin signaling. As insulin resistance is reported to be a risk factor for sporadic AD, this PS1‐mediated regulatory mechanism of brain insulin signaling may be causally associated with AD pathology.